EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Preclinical Safety Evaluation of Clinical‐Grade hESC‐Derived Multipotent Mesenchymal Stem Cells for Interstitial Cystitis

Jeong Min Shin iD, Ah Reum Kang iD, Dong Seol Gwak iD, Su Jin Kim iD, Jin Won Seo iD, Eun-Young Kim iD, Ki-Sung Hong iD, Se-Pill Park iD, Hyung-Min Chung iD

Stem Cells International · 2026-01 · 2026 (1)

DOI: 10.1155/sci/5539154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 18.08.2026. Verfasst von Jeong Min Shin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Mirae Cell Bio Co. Ltd., Seoul, Republic of Korea. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human embryonic stem cell (hESC)‐derived multipotent mesenchymal stem cells (MMSCs) offer therapeutic potential for interstitial cystitis (IC); however, safety concerns, such as tumorigenicity from residual undifferentiated hESCs, must be thoroughly addressed. To address these concerns, we conducted comprehensive in vitro and in vivo safety assessments of clinical‐grade MMSCs. Flow cytometry, qRT‐PCR, and/or RNA sequencing confirmed the absence of pluripotency markers, including OCT3/4 , TRA-1-60 , TRA-1-81 , and NANOG , in MMSCs. In good laboratory practice (GLP)‐compliant studies, BALB/c‐ nu/nu immunodeficient mice received a single intra‐detrusor muscle injection of MMSCs. No adverse clinical signs or immune responses were observed at doses corresponding to up to 6 × 10 9 cells in humans, the maximum feasible clinical dose based on body weight conversion. Furthermore, no tumor formation was detected for up to 52 weeks following either intra‐detrusor muscle or subcutaneous administration. Spiking studies showed teratoma formation only when undifferentiated hESCs exceeded 1%, supporting the absence of tumorigenic risk in the final MMSC product. Biodistribution analyses revealed that MMSCs remained localized at the injection site and were cleared from major organs within 10 days. These findings indicate that MMSCs contain no detectable hESCs within the sensitivity limits of the assays, exhibit no immunogenicity or tumorigenic potential, and are safe for intra‐detrusor muscle administration, supporting their clinical application as a cell‐based therapy for IC.

Schlagwörter

Stichwörter der Autor:innen

biodistributionhuman embryonic stem cellsinterstitial cystitismultipotent mesenchymal stem cellstumorigenicity

Autor:innen und Institutionen

  • Department of Research and Development, Mirae Cell Bio Co. Ltd., Seoul, Republic of Korea.
  • Department of Bio Medical Informatics, College of Applied Life Sciences, Jeju National University, Jeju, Republic of Korea, jejunu.ac.kr.

ORCID-Profile: Jeong Min Shin, Ah Reum Kang, Dong Seol Gwak, Su Jin Kim, Jin Won Seo, Eun-Young Kim, Ki-Sung Hong, Se-Pill Park, Hyung-Min Chung

Zitieren

APA

Shin, J. M., Kang, A. R., Gwak, D. S., Kim, S. J., Seo, J. W., Kim, E. Y., Hong, K. S., Park, S. P., & Chung, H. M. (2026). Comprehensive Preclinical Safety Evaluation of Clinical‐Grade hESC‐Derived Multipotent Mesenchymal Stem Cells for Interstitial Cystitis. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/5539154

Vancouver

Shin JM, Kang AR, Gwak DS, Kim SJ, Seo JW, Kim EY, et al. Comprehensive Preclinical Safety Evaluation of Clinical‐Grade hESC‐Derived Multipotent Mesenchymal Stem Cells for Interstitial Cystitis. Stem Cells International. 2026;2026(1). doi:10.1155/sci/5539154

BibTeX
@article{Shin2026,
  author = {Shin, Jeong Min and Kang, Ah Reum and Gwak, Dong Seol and Kim, Su Jin and Seo, Jin Won and Kim, Eun-Young and Hong, Ki-Sung and Park, Se-Pill and Chung, Hyung-Min},
  title = {Comprehensive Preclinical Safety Evaluation of Clinical‐Grade hESC‐Derived Multipotent Mesenchymal Stem Cells for Interstitial Cystitis},
  journal = {Stem Cells International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/sci/5539154}
}
Kostenlos starten →